Showing 1041-1050 of 3105 results for "".
Can the Private Practice Survive in the Age of Consolidation?
https://practicalneurology.com/columns/practice-management/can-the-private-practice-survive-in-the-age-of-consolidation/30326/In the rapidly changing health care economy, increasing regulation and the expanding influence of third-party payers are diminishing the physician's role.On Shaky Ground: Identifying Risk Factors For Parkinson's Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/on-shaky-ground-identifying-risk-factors-for-parkinsons-disease/30396/While new studies have raised interest in the possibility of identifying risk factors for Parkinson's disease, evidence remains weak.King v. Burwell and the Future of the PPACA
https://practicalneurology.com/columns/practice-management/king-v-burwell-and-the-future-of-the-ppaca/30563/A decision by the US Supreme Court on tax credit eligibility could have an impact on the viability of public health care exchanges.Neurologic Complications of Globally Prevalent Infectious Disorders: A Focus on Syphilis, Cysticercosis, and Tuberculosis
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/neurologic-complications-of-globally-prevalent-infectious-disorders-a-focus-on-syphilis-cysticercosis-and-tuberculosis/32153/In the presence of CNS infections, neurologists should have a high index of suspicion for syphilis, tuberculosis, or cysticercosis, especially in people from endemic areas and immunocompromised individuals.Neuromuscular Notes: Diagnosing Metabolic Myopathies
https://practicalneurology.com/diseases-diagnoses/neuromuscular/neuromuscular-notes-diagnosing-metabolic-myopathies/31831/Metabolic myopathies can be accurately and efficiently diagnosed by keeping key clinical features in mind.OnabotulinumtoxinA for Trigeminal Neuralgia Treatment
https://practicalneurology.com/diseases-diagnoses/headache-pain/onabotulinumtoxina-for-trigeminal-neuralgia-treatment/32127/There is a growing body of evidence suggesting that onabotulinumtoxinA is a safe and effective treatment for trigeminal neuralgia.Movement Disorders Moment: Asleep Deep Brain Stimulation
https://practicalneurology.com/diseases-diagnoses/movement-disorders/movement-disorders-moment-asleep-deep-brainstimulation/31563/Image-guided image-verified deep brain stimulation implantation provides safer and more accurate electrode placement.Corpus Callosum Stroke:
A Rare Localization for an Isolated Cerebral Infarctionhttps://practicalneurology.com/diseases-diagnoses/stroke/corpus-callosum-strokebra-rare-localization-for-an-isolated-cerebral-infarction/32067/A rare case of isolated corpus callosum infarction secondary to recurrent atherosclerotic carotid disease.CIDP in an Adolescent After Pfizer-BioNTech COVID-19 Vaccination
https://practicalneurology.com/diseases-diagnoses/neuromuscular/cidp-in-an-adolescent-after-pfizer-biontech-covid-19-vaccination/32057/A case of pediatric CIDP temporally related to the Pfizer-BioNTech COVID-19 vaccine; more information is needed to leverage the vaccine-related risk with the risk associated with primary COVID-19.Progressive Drug-Resistant Epilepsy & Behavior Changes
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/progressive-drug-resistant-epilepsy-behavior-changes/31840/Early diagnosis of progressive epilepsy is essential.